first glp-1 approved for weight loss BREAKING: The FDA has the oral pill obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill Hate needles? Wegovy's weight loss

Efficacy of GLP-1 formula on body weight in overweight and obese adults

Lassailly, G

Cell Metabolism, 34(3), 396-407.e6

Never combine GLP-1 medications without explicit provider guidance

A licensed doctor will review it and determine your eligibility

Methylene blue is theorized to provide hemodynamic support by combating the nitric oxide (NO) induced vasodilation in amlodipine overdose by acting as a NO scavenger, preventing NO production, and impeding cGMP production.[20] While there have been reports of hemodynamic improvements in those with refractory shock, the overall evidence behind its benefit is sparse.[20,22,3,5] Other treatments that have been described but not well studied included sodium bicarbonate infusion (thought to work by correcting the acidosis that enhances calcium channel blocker binding to L-type calcium channels), phosphodiesterase III inhibitors, levosimendan, L-carnitine, and mechanical support with an intra-aortic balloon pump.[5,23] Overall, these modalities are not recommended as the evidence supporting them is lacking, but they can be considered as a last resort in those not responding to the therapies previously described above